Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Saved in:
Bibliographic Details
Published in:Molecular Oncology
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301678985773060
collection WordPress RSS
FRELIP Feed Integration
container_title Molecular Oncology
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:61234
institution FRELIP
journal_source_facet Molecular Oncology
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model
title_auth PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model
title_full PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model
title_fullStr PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model
title_full_unstemmed PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model
title_short PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model
title_sort pak1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: a breast cancer model
topic Oncology
General
Oncology
url https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70286?af=R